Vanguard Group Inc Phathom Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,787,311 shares of PHAT stock, worth $28.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,787,311

Previous 2,778,687 0.31%

Holding current value

$28.9 Million

Previous $17.4 Million 53.43%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$2.29 - $10.9 $19,748 - $94,001	8,624 Added 0.31%	2,787,311 $26.7 Million
Q1 2025 May 09, 2025	SELL	$4.22 - $7.74 $3,688 - $6,764	-874 Reduced 0.03%	2,778,687 $17.4 Million
Q4 2024 Feb 11, 2025	BUY	$7.45 - $18.94 $620,123 - $1.58 Million	83,238 Added 3.09%	2,779,561 $22.6 Million
Q3 2024 Nov 13, 2024	BUY	$10.25 - $19.5 $4.97 Million - $9.45 Million	484,568 Added 21.91%	2,696,323 $48.7 Million
Q2 2024 Aug 13, 2024	BUY	$8.97 - $12.05 $2.09 Million - $2.8 Million	232,642 Added 11.75%	2,211,755 $22.8 Million
Q1 2024 May 10, 2024	BUY	$6.21 - $11.05 $140,867 - $250,658	22,684 Added 1.16%	1,979,113 $21 Million
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $236,031 - $361,644	33,767 Added 1.76%	1,956,429 $17.9 Million
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $1.85 Million - $2.83 Million	180,325 Added 10.35%	1,922,662 $19.9 Million
Q2 2023 Aug 14, 2023	BUY	$7.28 - $14.32 $4.11 Million - $8.09 Million	564,840 Added 47.97%	1,742,337 $25 Million
Q1 2023 May 15, 2023	BUY	$6.19 - $12.36 $624,521 - $1.25 Million	100,892 Added 9.37%	1,177,497 $8.41 Million
Q4 2022 Feb 10, 2023	BUY	$9.18 - $11.53 $980,892 - $1.23 Million	106,851 Added 11.02%	1,076,605 $12.1 Million
Q3 2022 Nov 14, 2022	SELL	$6.46 - $12.11 $5.91 Million - $11.1 Million	-915,098 Reduced 48.55%	969,754 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$6.2 - $15.5 $358,663 - $896,659	-57,849 Reduced 2.98%	1,884,852 $15.9 Million
Q1 2022 May 13, 2022	BUY	$11.55 - $20.06 $171,598 - $298,031	14,857 Added 0.77%	1,942,701 $26.4 Million
Q4 2021 Feb 14, 2022	BUY	$17.83 - $33.15 $2.04 Million - $3.79 Million	114,193 Added 6.3%	1,927,844 $37.9 Million
Q3 2021 Nov 12, 2021	BUY	$30.69 - $36.83 $7.81 Million - $9.37 Million	254,362 Added 16.31%	1,813,651 $58.2 Million
Q2 2021 Aug 13, 2021	BUY	$32.66 - $39.87 $50.9 Million - $62.2 Million	1,559,289 New	1,559,289 $52.8 Million

Others Institutions Holding PHAT

# of Institutions

138

Shares Held

60.5M

Call Options Held

1.35M

Put Options Held

1.19M

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $407M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Phathom Pharmaceuticals, Inc. Transaction History